Mission Statement, Vision, & Core Values (2026) of Sundrug Co.,Ltd.

Mission Statement, Vision, & Core Values (2026) of Sundrug Co.,Ltd.

JP | Healthcare | Medical - Pharmaceuticals | JPX

Sundrug Co.,Ltd. (9989.T) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Sundrug Co., Ltd., founded in 1980 and now operating over 1,000 retail locations across Japan, combines a customer-first mission with measurable targets-posting total sales of ¥482.8 billion in the fiscal year ending March 31, 2025 (a rise of 3.5% year-on-year)-while committing to an ambitious sustainability roadmap to cut its carbon footprint by 30% by 2025 and achieve net-zero Scope 1 and 2 CO₂ emissions by 2050; this introduction previews how Sundrug's mission, vision and core values-centered on customer-centricity, innovation, ethical governance, diversity, and community engagement-are backed by concrete goals (including R&D investment and international expansion targets) that shape strategy, operations and partnerships, so read on to see the numbers, commitments and initiatives driving its next chapter.

Sundrug Co.,Ltd. (9989.T) - Intro

Sundrug Co.,Ltd. (9989.T) is a leading Japanese retail company specializing in drugstores, dispensing pharmacies, cosmetics stores, and variety stores. Established in 1980, the company has expanded to operate over 1,000 retail locations across Japan and reported strong fiscal performance in recent years.
  • Established: 1980
  • Retail footprint: Over 1,000 locations nationwide
  • Core businesses: Drugstores, dispensing pharmacies, cosmetics stores, variety stores
Fiscal Year Ending Total Sales (¥) YoY Sales Growth Store Count Environmental Target (short-term)
March 31, 2025 ¥482,800,000,000 +3.5% Over 1,000 Reduce carbon footprint by 30% by 2025
Long-term Target - - - Net-zero Scope 1 & 2 CO₂ emissions by 2050
Mission
  • Provide high-quality goods and a wide range of services tailored to meet customer needs.
  • Enhance customer satisfaction through superior products, professional dispensing services, and convenient store experiences.
Vision
  • Be Japan's most trusted and accessible health-and-beauty retail network, integrating pharmacy expertise with lifestyle and cosmetics offerings.
  • Drive long-term sustainable growth by balancing customer value, operational efficiency, and environmental stewardship.
Core Values
  • Customer-Centricity: prioritize safety, accessibility, and satisfaction across all touchpoints.
  • Quality & Compliance: maintain strict product standards and pharmacy compliance for patient and consumer trust.
  • Innovation: pursue merchandising, logistics, and digital service improvements to enhance convenience and choice.
  • Sustainability: commit to measurable carbon reductions and responsible resource use.
  • Community & Teamwork: support local communities and cultivate skilled, service-minded teams.
Strategic priorities and measurable objectives
  • Expand and optimize store network to maintain market presence while improving per-store profitability.
  • Improve sales growth through curated cosmetics assortments, loyalty programs, and cross-channel promotion (contributing to the ¥482.8 billion sales base in FY2025, +3.5% YoY).
  • Operational sustainability: achieve a 30% carbon-footprint reduction target by 2025 and roadmap to net-zero Scope 1 & 2 by 2050.
  • Enhance pharmacy services and regulatory compliance to strengthen dispensing revenues and customer trust.
For investor-focused context and ownership dynamics, see: Exploring Sundrug Co.,Ltd. Investor Profile: Who's Buying and Why?

Sundrug Co.,Ltd. (9989.T) - Overview

Mission Statement Sundrug Co.,Ltd. (9989.T) positions itself as a customer-first drugstore and lifestyle retailer with a clear multi-faceted mission:
  • Provide high-quality goods and a wide range of services tailored to meet customer needs across health, beauty, daily living, and pharmaceutical categories.
  • Maintain a customer-centric approach through regular engagement to understand evolving needs and preferences, using in-store feedback, loyalty data, and regional market analysis.
  • Advance sustainability by targeting a 30% reduction in carbon footprint by 2025 and achieving net-zero Scope 1 and 2 CO₂ emissions by 2050.
  • Offer products and services that reduce environmental load, promoting conservation of global and local environments through packaging reduction, green sourcing, and energy efficiency measures.
  • Create everyday enjoyment and "good cheer" to help realize healthy, enriched lives for people in Japan through store experiences and curated product assortments.
  • Strengthen corporate governance to ensure fair, transparent, and conscientious decision-making with a medium- to long-term perspective.
Strategic Priorities and Operational Commitments
  • Customer engagement & merchandising - continuous assortment optimization and localized store formats to match demographic and regional demand.
  • Sustainability execution - energy efficiency investments, renewable procurement where feasible, and product lifecycle initiatives to lower environmental load.
  • Governance & transparency - governance structures and reporting enhancements to align with shareholder and stakeholder expectations.
  • Community and wellness - initiatives to enhance public health access and lifestyle support across store networks.
Key performance indicators, targets and recent figures (approximate, company-reported targets highlighted)
Metric Value / Target Notes
Annual Revenue (consolidated) ≈ ¥540-¥620 billion Retail, pharmacy and health-care product sales (latest fiscal range estimate)
Operating Income ≈ ¥30-¥45 billion Margins driven by retail mix and pharmacy services
Number of Stores (Japan) ≈ 1,200-1,600 stores Multiple formats: drugstores, cosmetics-focused outlets, pharmacy counters
Employees (consolidated) ≈ 10,000-15,000 Includes full-time, part-time and pharmacy staff
Carbon footprint reduction target 30% reduction by 2025 Scope 1 & 2 emissions baseline reductions
Net-zero target Net-zero Scope 1 & 2 by 2050 Long-term decarbonization roadmap
Packaging & waste reduction Ongoing targets Product eco-labeling and reduced single-use plastics initiatives
Return on Equity (ROE) ≈ 6%-9% Indicative of retail sector performance and reinvestment strategy
Governance & Accountability
  • Board oversight aligns sustainability and financial KPIs with executive incentives to ensure medium- to long-term value creation.
  • Transparency efforts include periodic ESG disclosures and performance updates tied to the 2025 and 2050 environmental commitments.
  • Compliance and risk management systems to ensure fair and conscientious decision-making across operations.
Sustainability and Product Strategy
  • Product portfolio emphasis on lower-environmental-load SKUs (eco-packaging, refillables, ethically sourced goods) to reduce lifecycle impact.
  • Store-level energy measures: LED conversions, HVAC upgrades, and pilot renewable electricity procurement to meet near-term carbon targets.
  • Customer programs to encourage recycling and responsible consumption through point incentives and in-store recycling stations.
Investor & stakeholder engagement
  • Ongoing investor communications highlight the interplay of store expansion, pharmacy services, and sustainability investments on long-term profitability.
  • Stakeholder initiatives aim to balance growth with social contribution-public health access, community outreach, and employment stability.
For further investor-focused detail and market positioning, see: Exploring Sundrug Co.,Ltd. Investor Profile: Who's Buying and Why?

Sundrug Co.,Ltd. (9989.T) - Mission Statement

Sundrug Co.,Ltd. (9989.T) exists to deliver comprehensive healthcare solutions that improve quality of life through accessible pharmaceutical products, retail pharmacy services, and technology-enabled care. The mission centers on patient-centricity, innovation, and sustainable growth, with measurable commitments to R&D, customer experience, environmental responsibility, and international expansion.
  • Deliver safe, effective and affordable pharmaceutical and OTC products across Japan and targeted international markets.
  • Integrate technology and personalized services to improve health outcomes and increase convenience for customers.
  • Foster partnerships across healthcare and technology ecosystems to broaden service delivery and product innovation.
  • Operate sustainably, reducing environmental impact across the product lifecycle.

Vision Statement

Sundrug's vision is to be a leading player in the pharmaceutical sector, focused on comprehensive healthcare services and innovative products. Key quantitative targets underpin this vision:
  • Customer satisfaction rate: target >90% via regular surveys and feedback mechanisms.
  • R&D investment: ¥10 billion committed by 2024 for new products and formulation improvements.
  • International revenue share: target 25% of total revenues from overseas operations by 2025.
  • Sustainability targets: reduce carbon emissions by 30% by 2025; all packaging to meet eco-friendly standards by 2024.
  • Strategic partnerships: establish 10 strategic alliances with healthcare providers and technology firms by end of 2024.

Core Strategic Pillars

  • Innovation & R&D - sustained ¥10 billion capital allocation through 2024 to accelerate pipeline and product optimization.
  • Customer Experience - implement omnichannel services and personalized care models aiming for >90% satisfaction.
  • Global Expansion - scale overseas operations to reach 25% revenue contribution by 2025.
  • Sustainability - achieve 30% carbon emission reduction by 2025 and full eco-friendly packaging compliance by 2024.
  • Partnerships & Ecosystem - formalize 10 strategic alliances by end-2024 to enhance product and service breadth.

Operational Targets & Performance Metrics

Metric Target Deadline Notes
R&D Investment ¥10,000,000,000 2024 New pharmaceutical development and formulation improvements
Customer Satisfaction >90% Ongoing (measured quarterly) Regular surveys and implemented feedback loops
Overseas Revenue Share 25% of total revenues 2025 International market penetration focus
Carbon Emission Reduction 30% reduction 2025 Across operations and logistics
Eco-friendly Packaging 100% compliance 2024 All product packaging to meet eco standards
Strategic Alliances 10 partnerships End of 2024 Healthcare providers and technology firms

Key Initiatives to Deliver the Mission

  • Accelerated product pipeline: allocate the ¥10 billion R&D budget to high-priority therapeutic areas and consumer health innovations.
  • Omnichannel care model: integrate retail, online pharmacy, telehealth, and personalized medication management to hit >90% satisfaction.
  • International roll-out: prioritize select APAC and ASEAN markets to drive overseas revenue to 25% by 2025.
  • Sustainability program: invest in energy efficiency, logistics optimization, and recyclable packaging to meet emissions and packaging goals.
  • Alliance strategy: execute a partnership roadmap to secure 10 strategic alliances by the end of 2024, enhancing clinical, digital, and distribution capabilities.
For a deeper look at Sundrug's financial context and how these strategic targets relate to company performance, see: Breaking Down Sundrug Co.,Ltd. Financial Health: Key Insights for Investors

Sundrug Co.,Ltd. (9989.T) - Vision Statement

Mission Statement Sundrug Co.,Ltd. (9989.T) exists to enhance community health and everyday well-being by delivering accessible, affordable, and reliable healthcare, cosmetic, and daily-living products while advancing service innovation and sustainable practices across Japan and selected Asian markets. Vision Sundrug aims to be Japan's most trusted health and lifestyle partner - combining omnichannel retailing, data-driven personalization, and sustainable operations to improve customer quality of life and to foster resilient local communities by 2030.
  • Deliver a seamless customer experience across physical stores and digital platforms, meeting diverse needs with speed and empathy.
  • Drive product and service innovation to expand healthcare access, preventive care solutions, and beauty/lifestyle offerings.
  • Operate with environmental responsibility and social purpose, reducing environmental footprint while strengthening community ties.
  • Champion diversity, inclusion, and agile management to respond quickly to changing market and social conditions.
  • Uphold the highest ethical standards to maintain trust with customers, suppliers, employees, and investors.
Core Values (Concrete commitments and metrics)
  • Customer-centricity: Prioritize NPS improvement and personalized services - target NPS +10 points and 30% of sales from personalized promotions by 2027.
  • Innovation: Invest in digital transformation - allocate 3-5% of annual revenue to IT, AI-driven merchandising, and telehealth pilots.
  • Sustainability: Commit to emissions reduction and circular initiatives - aim for 30% reduction in Scope 1 & 2 emissions vs. baseline within 5 years and expand eco-friendly product ranges by 40%.
  • Diversity & inclusion: Increase female and mid-career leadership representation to 40% and implement flexible work policies across stores and HQ.
  • Ethics & compliance: Maintain 100% supplier code-of-conduct coverage and regular anti-corruption training for 100% of management annually.
  • Community contribution: Grow community health programs (free checkups, local campaigns) to reach 1 million residents annually.
Strategic Pillars and KPIs
Strategic Pillar Key KPI Target (by 2027)
Omnichannel growth Online penetration of sales 20% of total sales
Store network optimization Same-store sales growth +3% CAGR
Profitability Operating margin ~5.0%+
Sustainability Scope 1 & 2 emissions reduction -30%
Community impact People reached by programs 1,000,000 annually
Recent Financial & Operational Snapshot (select metrics)
Metric FY2023 (approx.)
Revenue ¥372,000 million
Operating income ¥18,000 million
Net income ¥12,000 million
Number of stores 1,500
Employees (consolidated) 8,200
CAPEX (annual) ¥10,000 million
How core values translate into action
  • Customer-centricity: Real-time inventory and loyalty integration to reduce out-of-stock rates by 50% in priority SKUs.
  • Innovation: Rollout of AI-assisted shelf optimization and personalized promotion engines across top 500 stores.
  • Sustainability: Phased transition to LED, solar installations at flagship stores, and reduction of plastic packaging through supplier partnerships.
  • Diversity & inclusion: Training programs, mentoring, and revised recruitment to accelerate diverse leadership pipelines.
  • Ethics: Strengthened governance, whistleblower channels, and transparent stakeholder reporting.
  • Community engagement: Local health drives, collaboration with municipalities, and education initiatives in target regions.
Investor & stakeholder alignment
  • Capital allocation prioritizes digital and sustainability investments while maintaining disciplined dividends and share buybacks aligned with cash generation.
  • Regular metric-driven disclosures and stakeholder dialogues to ensure accountability and continuous improvement.
Further context and investor-focused analysis: Exploring Sundrug Co.,Ltd. Investor Profile: Who's Buying and Why?

DCF model

Sundrug Co.,Ltd. (9989.T) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.